Marjan Azin

437 total citations · 1 hit paper
22 papers, 237 citations indexed

About

Marjan Azin is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, Marjan Azin has authored 22 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Immunology and 7 papers in Dermatology. Recurrent topics in Marjan Azin's work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (6 papers). Marjan Azin is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (6 papers). Marjan Azin collaborates with scholars based in United States, South Korea and China. Marjan Azin's co-authors include Shadmehr Demehri, Michael S. Chang, Tomonori Oka, Tatsuya Hasegawa, Nir Hacohen, David Lieb, Thomas Eisenhaure, Marta Requesens, Thao H. Nguyen and Yevgeniy R. Semenov and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Marjan Azin

19 papers receiving 236 citations

Hit Papers

Cytotoxic CD4+ T cells eliminate senescent cells by targe... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjan Azin United States 7 98 79 58 45 40 22 237
Pascale Zwicky Switzerland 8 144 1.5× 34 0.4× 42 0.7× 63 1.4× 32 0.8× 12 262
Yemsratch T. Akalu United States 5 241 2.5× 65 0.8× 70 1.2× 71 1.6× 24 0.6× 6 347
Lucie Loyal Germany 6 126 1.3× 33 0.4× 49 0.8× 84 1.9× 20 0.5× 12 229
Feng-Li Xiao China 9 147 1.5× 29 0.4× 59 1.0× 89 2.0× 15 0.4× 18 249
Shunsuke Kanada Japan 11 284 2.9× 33 0.4× 88 1.5× 36 0.8× 16 0.4× 16 397
Yvonne S.L. Mak United States 4 57 0.6× 114 1.4× 58 1.0× 31 0.7× 12 0.3× 5 195
Tara Bardawil Lebanon 7 133 1.4× 22 0.3× 112 1.9× 112 2.5× 22 0.6× 13 321
Aishath Naeem United Kingdom 8 50 0.5× 20 0.3× 98 1.7× 60 1.3× 28 0.7× 11 234
Lena Möbus Finland 9 99 1.0× 16 0.2× 74 1.3× 168 3.7× 16 0.4× 21 316
Ronald Rudolf Germany 6 128 1.3× 29 0.4× 87 1.5× 24 0.5× 13 0.3× 8 197

Countries citing papers authored by Marjan Azin

Since Specialization
Citations

This map shows the geographic impact of Marjan Azin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjan Azin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjan Azin more than expected).

Fields of papers citing papers by Marjan Azin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjan Azin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjan Azin. The network helps show where Marjan Azin may publish in the future.

Co-authorship network of co-authors of Marjan Azin

This figure shows the co-authorship network connecting the top 25 collaborators of Marjan Azin. A scholar is included among the top collaborators of Marjan Azin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjan Azin. Marjan Azin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wan, Guihong, Bonnie W. Leung, Marjan Azin, et al.. (2025). Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events. Journal for ImmunoTherapy of Cancer. 13(5). e010638–e010638. 3 indexed citations
2.
Oka, Tomonori, Sally K. Sommers Smith, Heehwa G. Son, et al.. (2025). T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions. Journal of Clinical Investigation. 135(1). 1 indexed citations
3.
Azin, Marjan, Bonnie W. Leung, Katie Roster, et al.. (2025). Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors. Journal of the American Academy of Dermatology. 93(6). 1456–1463.
4.
Oka, Tomonori, Sally K. Sommers Smith, Heehwa G. Son, et al.. (2025). Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Reports. 44(5). 115561–115561. 1 indexed citations
5.
Wang, Dongyao, Jiao Huang, Yun Xia, et al.. (2025). Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nature Communications. 16(1). 5360–5360. 2 indexed citations
6.
Oka, Tomonori, Tatsuya Hasegawa, Marjan Azin, et al.. (2024). Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis. SHILAP Revista de lepidopterología. 5(1). 100324–100324. 2 indexed citations
7.
Park, Jong Ho, Heehwa G. Son, Marjan Azin, et al.. (2024). Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression. Nature Communications. 15(1). 4099–4099. 18 indexed citations
8.
Wan, Guihong, Bonnie Leung, Chenhong Lin, et al.. (2024). 208 Dupilumab for managing cutaneous immunotherapy toxicities does not impact mortality. Journal of Investigative Dermatology. 144(8). S36–S36. 1 indexed citations
9.
Azin, Marjan, et al.. (2023). Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers. SHILAP Revista de lepidopterología. 3(6). 100221–100221. 3 indexed citations
10.
Hasegawa, Tatsuya, Tomonori Oka, Marjan Azin, et al.. (2023). Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen. Cell. 186(7). 1417–1431.e20. 85 indexed citations breakdown →
11.
Xia, Yun, Kaiwen Li, Feng Shao, et al.. (2023). Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment. Journal of Clinical Investigation. 133(20). 4 indexed citations
12.
Azin, Marjan, et al.. (2023). TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome. JCI Insight. 8(13). 8 indexed citations
13.
Park, Jong Ho, et al.. (2023). Nuclear IL-33 in Fibroblasts Promotes Skin Fibrosis. Journal of Investigative Dermatology. 143(7). 1302–1306.e4. 3 indexed citations
14.
Requesens, Marta, et al.. (2023). Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells. Frontiers in Immunology. 13. 1098445–1098445. 31 indexed citations
15.
Boieri, Margherita, et al.. (2022). Thymic stromal lymphopoietin-stimulated CD4+ T cells induce senescence in advanced breast cancer. Frontiers in Cell and Developmental Biology. 10. 1002692–1002692. 9 indexed citations
16.
Azin, Marjan, et al.. (2022). Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development. Cancers. 14(9). 2173–2173. 7 indexed citations
17.
Azin, Marjan & Shadmehr Demehri. (2022). STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications. Journal of Investigative Dermatology. 142(4). 1007–1009. 4 indexed citations
18.
Azin, Marjan, Julia E. Seaman, Isabel Elaine Allen, et al.. (2022). Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment. SHILAP Revista de lepidopterología. 2(3). 100104–100104. 4 indexed citations
19.
Azin, Marjan, et al.. (2022). Lethal Dermal Sarcoma in Immunosuppressed Patients. The Oncologist. 27(9). e759–e761.
20.
Azin, Marjan & Shadmehr Demehri. (2021). Innate Lymphoid Cells: New Targets for Cutaneous Squamous Cell Carcinoma Immunotherapy. Journal of Investigative Dermatology. 141(10). 2320–2322. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026